With SCTR's support, MUSC researchers have shown that a naturally occurring antioxidant improves immune-based therapies by modulating T-cells.
The South Carolina Clinical & Translational Research (SCTR) Institute, a statewide NIH-funded Clinical and Translational Science Award (CTSA) Program Hub based at MUSC, is the catalyst for changing the culture of biomedical research in South Carolina. It facilitates the sharing of resources and expertise and streamlines research-related processes to bring about large-scale change in the state’s clinical and translational research efforts. SCTR’s partners include the Medical University of South Carolina (MUSC), Clemson University, Health Sciences South Carolina, and the University of South Carolina. Our vision is to improve health outcomes and quality of life for South Carolinians by translating scientific discoveries into evidence-based clinical practice. Learn more about SCTR.
SCTR’s innovative research resources, funding opportunities, training programs, and other activities foster the growth of clinical and translational research across the state.
SCTR has a portfolio of research resources created to assist investigators and stakeholders across all the stages of translational research, from the bench to the bedside to the broader community.Research Resources
SCTR is training the workforce needed to build and sustain robust translational research in South Carolina. It has formal Career Development and Predoctoral Training programs and funds training for others who engage in or support clinical and translational research.Education and Training
SCTR also cultivates new research teams and supports exploration of new research areas that address South Carolina’s health priorities. Each year, SCTR issues funding opportunity announcements seeking research proposals from new teams, junior investigators, and predoctoral trainees.Funding Opportunities